⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diaminopropanoic Acid SCHEMBL42470 | 1.00 | — | — | |
| Diaminopropanoic Acid SCHEMBL297184 | 1.00 | — | — | |
| Diaminopropanoic Acid SCHEMBL29479233 | 1.00 | — | — | |
| Diaminopropanoic Acid SCHEMBL5548567 | 0.97 | — | — | |
| Diaminopropanoic Acid SCHEMBL22390091 | 0.97 | — | — | |
| Diaminopropanoic Acid SCHEMBL1627433 | 0.97 | PTGS1 (0.52) | — | |
| Diaminopropanoic Acid SCHEMBL29400892 | 0.97 | — | — | |
| Diaminopropanoic Acid SCHEMBL1270384 | 0.97 | — | — | |
| Diaminopropanoic Acid SCHEMBL5972751 | 0.97 | — | — | |
| Diaminopropanoic Acid SCHEMBL5972746 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 625 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122074077-A | Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte stimulating hormone analogs for imaging or therapy | 省卫生服务机构 | 2026-05-22 | — | — | CN | claimed |
| CN-122070294-A | Stable vitreous material based on histidine, arginine and glutamic acid amino acids | 阵序补丁有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-12616761-B2 | CXCR4-targeting compounds | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2026-05-05 | — | — | US | claimed |
| EP-4696700-A1 | LONG-ACTING K-OPIOID RECEPTOR AGONIST | Chengdu Aoda Biotechnology Co., Ltd (CN) | 2026-02-18 | — | — | EP | claimed |
| EP-4696699-A1 | ? OPIOID RECEPTOR AGONIST AND USE THEREOF | Chengdu Aoda Biotechnology Co., Ltd. (CN) | 2026-02-18 | — | — | EP | claimed |
| EP-4691482-A1 | LONG-ACTING CALCITONIN ANALOG | Chengdu Aoda Biotechnology Co., Ltd. (CN) | 2026-02-11 | — | — | EP | claimed |
| US-20260015389-A1 | V1A Receptor Partial Agonist and Method of Use | PHARMALN CORP (US) | 2026-01-15 | — | — | US | claimed |
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-11-06 | — | — | US | claimed |
| US-12410211-B2 | V1A receptor partial agonist and method of use | PHARMAIN CORPORATION (US) | 2025-09-09 | — | — | US | claimed |
| US-20250249113-A1 | LIGAND-DRUG-CONJUGATES WITH IMPROVED PHARMACOKINETIC AND DRUG RELEASE PROPERTIES | DEBIOPHARM RESEARCH & MANUFACTURING SA (CH) | 2025-08-07 | — | — | US | claimed |
| US-20190024135-A1 | COMPOSITIONS FOR IN SITU LABELING OF BACTERIAL CELL WALLS WITH FLUOROPHORES AND METHODS OF USE THEREOF | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION | 2019-01-24 | — | — | US | claimed |
| EP-3334447-A1 | CCK2R-DRUG CONJUGATES | Endocyte, Inc. (US) | 2018-06-20 | — | — | EP | claimed |
| WO-2017030859-A1 | CCK2R-DRUG CONJUGATES | ENDOCYTE, INC. (US) | 2017-02-23 | — | — | WO | claimed |
| US-20160222430-A1 | D-ALA-D-ALA-BASED DIPEPTIDES AS TOOLS FOR IMAGING PEPTIDOGLYCAN BIOSYNTHESIS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION | 2016-08-04 | — | — | US | claimed |
| US-20150191763-A1 | COMPOSITIONS FOR IN SITU LABELING OF BACTERIAL CELL WALLS WITH FLUOROPHORES AND METHODS OF USE THEREOF | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION | 2015-07-09 | — | — | US | claimed |
| WO-2015038764-A1 | D-ALA-D-ALA-BASED DIPEPTIDES AS TOOLS FOR IMAGING PEPTIDOGLYCAN BIOSYNTHESIS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2015-03-19 | — | — | WO | claimed |
| US-20140112976-A1 | Cyclic Peptides with an Anti-Neoplasic and Anti-Angiogenic Activity | CENTRO DE INGENIERIA GENETICA BIOTECNOLOGIA (CU) | 2014-04-24 | — | — | US | claimed |
| EP-2690107-A2 | CYCLIC PEPTIDES WITH AN ANTI-NEOPLASIC AND ANTI-ANGIOGENIC ACTIVITY | Centro De Ingenieria Genetica Y Biotecnologia (CU) | 2014-01-29 | — | — | EP | claimed |
| CN-103534265-A | Cyclic peptides with an anti-neoplasic and anti-angiogenic activity | CT INGENIERIA GENETICA BIOTECH | 2014-01-22 | — | — | CN | claimed |
| WO-2013159078-A1 | COMPOSITIONS FOR IN SITU LABELING OF BACTERIAL CELL WALLS WITH FLUOROPHORES AND METHODS OF USE THEREOF | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2013-10-24 | — | — | WO | claimed |